Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award: Canada Graduate Scholarships

Université de Sherbrooke

$105,000.00

Role of DUSP4 in diabetic nephropathy and end-stage renal disease

FY 2020-21

Summary
Diabetic nephropathy (DN) is a renal complication affecting many diabetic patients and is one of the preeminent causes of renal insufficiency leading to dialysis or renal transplant. Our project is based on podocytes, important cells for blood filtration in the kidneys. Their loss of function and death is an early event in the development of diabetic nephropathy. Ultimately, structural changes will get worse and lead to complete renal decline (ESRD). DUSP4, a molecule that regulates proteins involved in cell death, is important for renal function. We have observed a decrease in DUSP4 levels in diabetic kidneys. Previous results have emphasized the importance of DUSP4 in the kidney since whole-body removal of DUSP4 worsens characteristics of diabetic nephropathy. To this day, the kidneys of diabetic patients suffering from ESRD are said to have reached the point of no return. Thus, it is critical to find treatments that could stop/slow down the progression of kidney problems. With the use of mice that have elevated levels of DUSP4 specifically in podocytes, our objective is to determine the clinical significance of DUSP4 in the prevention of diabetic nephropathy. Our hypothesis is that increased levels of DUSP4 in podocytes will prevent the onset of kidney problems in diabetic mice and will also re-establish renal function once the disease has already started. Secondly, with the use of a mouse model of ESRD (adenine-rich food), our 2nd objective is to investigate the role of DUSP4 in the progression towards complete renal insufficiency, an area that lacks research. We hypothesize that DUSP4 deletion will accelerate the progression and onset of complete renal insufficiency. My projects will help us better understand the mechanisms leading to DN and ESRD as well as the importance of DUSP4 in the kidney while ultimately contributing to support patients affected by these conditions to potentially give them a better quality of life.
Program
Doctoral Research Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
439702
Name
Rousseau Marina
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Role of DUSP4 in diabetic nephropathy and end-stage renal disease
Programtype2
Studentship Programs
Orgnameinp2
Université de Sherbrooke
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Adenine-Induced Fibrosis; Diabetic Nephropathy; Dusp4; End-Stage Renal Disease; Podocyte Loss
Abstract
Diabetic nephropathy (DN) is a renal complication affecting many diabetic patients and is one of the preeminent causes of renal insufficiency leading to dialysis or renal transplant. Our project is based on podocytes, important cells for blood filtration in the kidneys. Their loss of function and death is an early event in the development of diabetic nephropathy. Ultimately, structural changes will get worse and lead to complete renal decline (ESRD). DUSP4, a molecule that regulates proteins involved in cell death, is important for renal function. We have observed a decrease in DUSP4 levels in diabetic kidneys. Previous results have emphasized the importance of DUSP4 in the kidney since whole-body removal of DUSP4 worsens characteristics of diabetic nephropathy. To this day, the kidneys of diabetic patients suffering from ESRD are said to have reached the point of no return. Thus, it is critical to find treatments that could stop/slow down the progression of kidney problems. With the use of mice that have elevated levels of DUSP4 specifically in podocytes, our objective is to determine the clinical significance of DUSP4 in the prevention of diabetic nephropathy. Our hypothesis is that increased levels of DUSP4 in podocytes will prevent the onset of kidney problems in diabetic mice and will also re-establish renal function once the disease has already started. Secondly, with the use of a mouse model of ESRD (adenine-rich food), our 2nd objective is to investigate the role of DUSP4 in the progression towards complete renal insufficiency, an area that lacks research. We hypothesize that DUSP4 deletion will accelerate the progression and onset of complete renal insufficiency. My projects will help us better understand the mechanisms leading to DN and ESRD as well as the importance of DUSP4 in the kidney while ultimately contributing to support patients affected by these conditions to potentially give them a better quality of life.
Competitiondate
202011
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Rousseau, Marina
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~